Business and Finance

Two Canadian Accucaps facilities join global network of 11 Catalent RP Scherer Softgel locations

Allergan’s big commitment to NJ; U. of Michigan converts pharma facilities to healthcare and education

Upcoming trial could explore the intricacies of ‘alternative fulfillment’ via specialty pharmacies

An Amazon-like model for creating an open market for wholesalers to reach customers

Will employer benefit plans lose their enthusiasm for PBMs?

Revenues and earnings were up for the year; stock jumps 8.8% in the day

McKesson disappoints on Q2 earnings call; stock drops 23%. Update: Cardinal reports more revenue, less profit

Price growth is less than branded growth, but higher than inflation

Company may have erroneously been operating under a generic classification

New company is to be known as QuintilesIMS

Drug dispensing, point of care testing and diagnostics are beneficiaries

Drug Channel’s analysis of Inc. 5000 shows some eye-popping growth

CIS by Deloitte seeks to provide a comprehensive service for revenue management

Mylan CEO sticks to authorized-generic strategy for price relief

Roche could overtake Novartis as the No. 1 global firm by then, says Evaluate Pharma

Pharmacy benefit managers feel some marketplace heat even as they establish new benefit programs

Walgreens-Rite Aid merger is still pending

EpiPen controversy has a new twist: paying lower rebates to state Medicaid programs

Sponsored by TGaS Advisors

Presidential politicking adds momentum to the growing backlash, and not just for Mylan

Healthcare research firm calls out the alarmist predictions over PCSK9s and other new drugs

CROs are expanding their scope of services

Deal deepens Teva’s business in generics